SUDAFED PE SEVERE COLD OTC
Generic Name and Formulations:
Acetaminophen 325mg, diphenhydramine HCl 12.5mg, phenylephrine HCl 5mg; per caplet.
McNeil Consumer Healthcare
Indications for SUDAFED PE SEVERE COLD:
Nasal congestion, rhinorrhea, headache, sore throat, fever.
2 caplets every 4hrs as needed; max 12 caplets/24hrs.
<6yrs: individualize. 6–11yrs: 1 caplet every 4hrs as needed; max 5 caplets/24hrs.
Within 14 days of MAOIs. Concomitant acetaminophen or diphenhydramine (including topical) products.
Cardiovascular disease. Hypertension. Liver disease. Thyroid disease. Glaucoma. Diabetes. Asthma. Lower respiratory disorders. GI or GU obstruction.
See Contraindications. Increased risk of liver damage with ≥3 alcoholic drinks/day. Hypertensive crisis with MAOIs. β-blockers may increase the pressor effects of sympathomimetics. Other CNS depressants potentiated. Antihypertensives antagonized.
Analgesic + antihistamine + sympathomimetic.
Drowsiness, anticholinergic effects, nervousness, dizziness, insomnia, excitability in children.
Severe Cold—12, 24
Endocrinology Advisor Articles
- Soluble Klotho Levels Predictive of Kidney Failure in Type 2 Diabetes
- HbA1c Levels Predictive of Liraglutide Treatment Response in T2D
- Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes
- ADA Updates Guidelines for Cardiovascular Risk Management in Diabetes
- Clinicians May Be Overtreating Older Patients With Diabetes
- USPSTF Issues Recommendation for Vitamin D, Calcium Supplementation for Fracture Prevention
- Obesity Risk in Infants Born to Women With Diabetes
- Insulin-Treated Diabetes Reduces Dysglycemia-Related Mortality in Sepsis
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Oxyntomodulin Augments Glucose Homeostasis